Liver Transplantation Market
Geographically North America dominated global liver transplantation market driven by best in the class healthcare infrastructure, advanced facilities and awareness and higher spending by the citizens towards healthcare expenditure. North America was followed by Europe and Asia-Pacific as second and third largest market for liver transplantation surgery market. Asia Pacific is projected to have fastest growth, owing to rapidly increasing healthcare infrastructure, increased spending, government initiatives and increasing awareness amongst population, and growing medical tourism industry in developing nations such as China, and India in this region.
This report identifies the global liver transplantation market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global liver transplantation market.
This report segments global liver transplantation market on the basis of treatment, end-user and regional market as follows:
Liver Transplantation Market, By Treatment: Liver Transplantation Surgery, Post-Surgery Anti-Rejection Treatment(Cyclosporine, Tacrolimus, Sirolimus, Prednisone, Azathioprine, Mycophenolate Mofetil)
Liver Transplantation Market, By End-Usert: Hospitals, Adult Liver Transplantation Centers, Ambulatory Surgical Centers
This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region
This report identifies all the major companies operating in the liver transplantation market. Some of the major companies’ profiles in detail are as follows:
Conatus Pharmaceuticals Inc.
Dompe Farmaceutici S.p.A.
RedHill Biopharma Ltd.
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
2. Executive Summary
3. Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis
4. Liver Transplantation Market– Market Forces
4.1.1. Growing prevalence of Hepatitis A, B and C
4.2.1. Inadequate number of donors
4.3.1. Emerging economies
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition
5. Liver Transplantation Market– Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors
6. Liver Transplantation Market, By Treatment
6.1. Liver Transplantation Surgery
6.2. Surgery Anti-Rejection Treatment
6.2.6. Mycophenolate Mofetil
7. Liver Transplantation Market, By End-User
7.2. Adult Liver Transplantation Centers
7.3. Ambulatory Surgical Centers
8. Liver Transplantation Market, By Geography
8.1.7. Rest of Europe
8.2. Asia Pacific
8.2.4. South Korea
8.2.5. Rest of Asia-Pacific
8.3. North America
8.4. Rest of the World (RoW)
8.4.2. Rest of RoW
9. Liver Transplantation – Market Entropy
9.2. Technological Developments
9.3. Merger & Acquisitions, and Joint Ventures
9.4. Supply- Contract
10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
10.2. Conatus Pharmaceuticals Inc.
10.3. Digna Biotech
10.5. Dompe Farmaceutici S.p.A.
10.6. Isogenis, Inc.
10.7. RedHill Biopharma Ltd.
10.8. Thompson Surgical
10.9. Integra Life sciences
10.10. Dompe Farmaceutici S.p.A
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11.3. Research Methodology
11.5. Compilation of Expert Insights